RT Journal Article
SR Electronic
T1 Screening for obstructive sleep apnoea (OSA) in patients attending a hypertension clinic with features of the metabolic syndrome
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP 1664
VO 40
IS Suppl 56
A1 Peter Coss
A1 Finbarr O'Connell
A1 Michele Agnew
A1 Patrick Goodman
YR 2012
UL http://erj.ersjournals.com/content/40/Suppl_56/1664.abstract
AB Aim: To see if OSA is a common finding in patients with Metabolic Syndrome.Background: Metabolic Syndrome has been described as a constellation of risk factors for cardiovascular disease (CVD). The WHO places the incidence at 21% of the population. OSA syndrome occurs in 2-4% of males and females. Both conditions represent a significant burden to the health service in terms of diagnosis, treatment and management. Volunteers agreed to undergo a home cardiopulmonary sleep study and interview with questionnaires including the Epworth score. Studies were manually scored to determine the Apnoea Hypopnoea Index.Results: 35 volunteers were recruited. This yielded 32 studies (10 female) that were analysed. Mean age: 50yrs (Range 26 – 73), mean BMI: 37.5 (±5.8). Significant OSA (AHI>5) was found in 7 females (80%) and 20 male (88%) subjects, 86% overall.View this table:Summary FindingsConclusion: OSA is prevalent in this group of patients and was not the primary reason for attendance. Epworth Score alone was a poor predictor of sleep breathing disorder in those with mild to moderate AHI. OSA is a risk factor for CVD and so we suggest that there should be routine screening for OSA in this particular patient group.